Literature DB >> 35705636

Alcohol use disorder is associated with DNA methylation-based shortening of telomere length and regulated by TESPA1: implications for aging.

Jeesun Jung1, Daniel L McCartney2, Josephin Wagner1, Daniel B Rosoff1, Melanie Schwandt3, Hui Sun3, Corinde E Wiers4, Luana Martins de Carvalho4, Nora D Volkow4, Rosie M Walker2, Archie Campbell2, David J Porteous2, Andrew M McIntosh2, Riccardo E Marioni2, Steve Horvath5,6, Kathryn L Evans2, Falk W Lohoff7.   

Abstract

Chronic heavy alcohol consumption is associated with increased mortality and morbidity and often leads to premature aging; however, the mechanisms of alcohol-associated cellular aging are not well understood. In this study, we used DNA methylation derived telomere length (DNAmTL) as a novel approach to investigate the role of alcohol use on the aging process. DNAmTL was estimated by 140 cytosine phosphate guanines (CpG) sites in 372 individuals with alcohol use disorder (AUD) and 243 healthy controls (HC) and assessed using various endophenotypes and clinical biomarkers. Validation in an independent sample of DNAmTL on alcohol consumption was performed (N = 4219). Exploratory genome-wide association studies (GWAS) on DNAmTL were also performed to identify genetic variants contributing to DNAmTL shortening. Top GWAS findings were analyzed using in-silico expression quantitative trait loci analyses and related to structural MRI hippocampus volumes of individuals with AUD. DNAmTL was 0.11-kilobases shorter per year in AUD compared to HC after adjustment for age, sex, race, and blood cell composition (p = 4.0 × 10-12). This association was partially attenuated but remained significant after additionally adjusting for BMI, and smoking status (0.06 kilobases shorter per year, p = 0.002). DNAmTL shortening was strongly associated with chronic heavy alcohol use (ps < 0.001), elevated gamma-glutamyl transferase (GGT), and aspartate aminotransferase (AST) (ps < 0.004). Comparison of DNAmTL with PCR-based methods of assessing TL revealed positive correlations (R = 0.3, p = 2.2 × 10-5), highlighting the accuracy of DNAmTL as a biomarker. The GWAS meta-analysis identified a single nucleotide polymorphism (SNP), rs4374022 and 18 imputed ones in Thymocyte Expressed, Positive Selection Associated 1(TESPA1), at the genome-wide level (p = 3.75 × 10-8). The allele C of rs4374022 was associated with DNAmTL shortening, lower hippocampus volume (p < 0.01), and decreased mRNA expression in hippocampus tissue (p = 0.04). Our study demonstrates DNAmTL-related aging acceleration in AUD and suggests a functional role for TESPA1 in regulating DNAmTL length, possibly via the immune system with subsequent biological effects on brain regions negatively affected by alcohol and implicated in aging.
© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Entities:  

Year:  2022        PMID: 35705636     DOI: 10.1038/s41380-022-01624-5

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  58 in total

Review 1.  Telomeres and cardiovascular disease risk: an update 2013.

Authors:  Peter M Nilsson; Hanna Tufvesson; Margrét Leosdottir; Olle Melander
Journal:  Transl Res       Date:  2013-06-07       Impact factor: 7.012

2.  A lifetime history of alcohol use disorder increases risk for chronic medical conditions after stable remission.

Authors:  Tomoko Udo; Elizabeth Vásquez; Benjamin A Shaw
Journal:  Drug Alcohol Depend       Date:  2015-10-13       Impact factor: 4.492

3.  Pharmacotherapies and personalized medicine for alcohol use disorder: a review.

Authors:  Falk W Lohoff
Journal:  Pharmacogenomics       Date:  2020-08-18       Impact factor: 2.533

4.  Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Zhensheng Liu; Karen A Pooley; Alison M Dunning; Ulrika Svenson; Göran Roos; H Dean Hosgood; Min Shen; Qingyi Wei
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

5.  Association of High-Intensity Binge Drinking With Lipid and Liver Function Enzyme Levels.

Authors:  Daniel B Rosoff; Katrin Charlet; Jeesun Jung; Jisoo Lee; Christine Muench; Audrey Luo; Martha Longley; Kelsey L Mauro; Falk W Lohoff
Journal:  JAMA Netw Open       Date:  2019-06-05

6.  Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2.

Authors:  Audrey Luo; Jeesun Jung; Martha Longley; Daniel B Rosoff; Katrin Charlet; Christine Muench; Jisoo Lee; Colin A Hodgkinson; David Goldman; Steve Horvath; Zachary A Kaminsky; Falk W Lohoff
Journal:  Neuropsychopharmacology       Date:  2019-08-29       Impact factor: 7.853

7.  Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.

Authors:  Daniel B Rosoff; George Davey Smith; Nehal Mehta; Toni-Kim Clarke; Falk W Lohoff
Journal:  PLoS Med       Date:  2020-12-04       Impact factor: 11.069

8.  DNA methylation age is accelerated in alcohol dependence.

Authors:  Allison D Rosen; Keith D Robertson; Ryan A Hlady; Christine Muench; Jisoo Lee; Robert Philibert; Steve Horvath; Zachary A Kaminsky; Falk W Lohoff
Journal:  Transl Psychiatry       Date:  2018-09-05       Impact factor: 6.222

9.  Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden.

Authors:  J Westman; K Wahlbeck; T M Laursen; M Gissler; M Nordentoft; J Hällgren; M Arffman; U Ösby
Journal:  Acta Psychiatr Scand       Date:  2014-09-20       Impact factor: 6.392

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.